Clinical trials play a pivotal role in advancing our understanding and treatment of Alzheimer’s Disease and dementia. These trials focus on testing new medications, therapies, and interventions aimed at improving symptoms, slowing disease progression, or preventing onset. They involve diverse participant recruitment to ensure findings are applicable across different groups. Researchers rigorously evaluate safety, efficacy, and potential side effects of experimental treatments. Participation not only offers access to cutting-edge care but also contributes to scientific knowledge crucial for future advancements. By testing new approaches, these trials are instrumental in the ongoing pursuit of effective treatments and, ultimately, a cure for Alzheimer’s Disease and various types of dementia.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States